A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Clinical trial NCT07205822 · RECRUITING
Trial details
- NCT number
- NCT07205822
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-30
- Primary completion
- 2028-02-02
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.